Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 71Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 123Head and Neck Neoplasms 80Oropharyngeal Neoplasms 19Carcinoma, Non-Small-Cell Lung 15Laryngeal Neoplasms 13Carcinoma, Squamous Cell 13Salivary Gland Neoplasms 12Carcinoma 12Mouth Neoplasms 11Ovarian Neoplasms 9Neoplasm Metastasis 9Nasopharyngeal Carcinoma 9Nasopharyngeal Neoplasms 8Esophageal Neoplasms 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Lung Neoplasms 6Hypopharyngeal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Small Cell Lung Carcinoma 5Recurrence 5Papillomavirus Infections 5Melanoma 5Breast Neoplasms 5Urinary Bladder Neoplasms 4Tongue Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4

Interventions

pembrolizumab 3tislelizumab 1spartalizumab 1fludarabine phosphate 1bemarituzumab 1Tablets 1Specimen Handling 1Solutions 1Rogaratinib 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Interleukin-13 1IFL protocol 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Biopsy 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Carboplatin × Head & Neck × Clear all
NCT04452214 2023-07-14

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Cantargia AB

Phase 1 Completed
19 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡